补充替代医学与现代医学中英文对照详解.pptVIP

Comparison of recurrent angina (RA) 两组复发心绞痛的比较 ** ** * Comparison of clinical end-point event 两组临床终点事件的比较 Note: There was significant difference between the two groups(p0.05). Death 死亡 0 0.00 0 0.00 Nonfatal MI 非致命性心梗 1 0.65 1 0.65 Repeat PCI 重复介入治疗 15 9.74 31 20.13 Event 终点事件 Treatment 治疗组 Control 对照组 N (%) N (%) CABG 冠脉搭桥 0 0.00 3 1.95 * 多中心、双盲随机、安慰剂对照方法，证明活血化瘀中药制剂预防冠心病介入治疗后再狭窄形成和心绞痛复发，改善患者长期预后。 Multi-center, double-blind, randomized, placebo-controlled methods proved that TCM can prevent the restenosis after PCI and recurrence of angina, and improve long-term prognosis of patients. * 在IRA恢复再通冠脉血流灌注良好的情况下仍有25％以上患者发生微循环血流No－reflow After restoring coronary reperfusion of IRA, there are more than 25% of patients without microcirculatory blood flow 3.益气养阴活血法改善AMI血运重建后心肌灌注 Tonifying Qi, nourishing yin and promoting the blood circulation to improve myocardial perfusion after revascularization for AMI * 临床设计：多中心、双盲随机、安慰对照 Design: A multicenter, double-blind, randomized, controlled placebo) 治疗方法：治疗组100例在西医的基础上加心悦胶囊、丹参片；对照组采用西医常规治疗 Treatment: Treatment group, 100 cases, adding Danshen Tablet and Xinyue capsule to western medicine; Control group, conventional Western medicine 观察指标：声学超声造影显示的心肌组织灌注、生命质量和终点事件 Index: acoustic ultrasound imaging showed myocardial perfusion, the quality of life and end-point events 实际入选例数(actual number of selected cases )：182例（91％） 脱落例数(number of loss follow-up cases)：11例（6.04％） * 心脏事件发生率(Incidence of heart event) SAQ生活质量积分 SAQ life quality score 负荷正常心肌百分比 The percentage of normal myocardium 声学造影结果(Acoustic imaging results ) 半年临床观察结果(clinical observation results of half year) * 改善左室收缩功能和心肌运动 Improving the left heart function myocardial movement 增加正常心肌比率 Increasing the ratio of normal myocardium 改善微循环血流灌注 Improving the microcirculation perfusion 减少心血管事件的发生 Reducing the cardiovascular incidence 提高患者的生活质量 Improving the life quality